Highlander Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,500
Closed -$218K 24
2022
Q3
$218K Hold
2,500
0.32% 21
2022
Q2
$284K Hold
2,500
0.37% 22
2022
Q1
$324K Hold
2,500
0.41% 20
2021
Q4
$451K Buy
+2,500
New +$434K 0.55% 19

Other funds holding OMCL

Highlander Partners's OMCL Position: Q4 2022 in Review

Highlander Partners sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 2,500 shares — an estimated $218K sold.

Highlander Partners first reported a position in OMCL in Q4 2021 and held it in 4 quarters. The position peaked at $451K in Q4 2021. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Highlander Partners reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Highlander Partners sold 2,500 Omnicell shares in Q4 2022, an estimated $218K.
  • Highlander Partners first reported a position in Omnicell in Q4 2021 and held it in 4 quarters.
  • Highlander Partners's Omnicell position peaked at $451K in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Highlander Partners's 13F filing for Q4 2022, filed 3 Feb 2023.